CDTX Chrysa Mineo buys $49K worth of shares
Jun 05, 2025, 4:35 AM
0.00%
What does CDTX do
Cidara Therapeutics, a San Diego-based biotechnology company with 69 employees, focuses on developing targeted immunotherapies for serious diseases, including oncology and antiviral treatments. Its lead candidate, CBO421, targets solid tumors, while CD388 addresses influenza prevention and treatment.
Chrysa Mineo bought 2,270 shares of CDTX on 2 June at $21.71 per share, worth a total of $49K. They now own 2,270 CDTX shares.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.